| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.lalchandanipathlab.com | |
| Market Cap | 11.61 Cr. | |
| Enterprise Value(EV) | 12.76 Cr. | 2021-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.15 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 12.46 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 49.82 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 22.01 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 1.22 | Calculated using Price: 26.80 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 0.43 Cr. | 4,333,068 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| They are a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through their integrated network, they offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. | ||
| 1 Day |
|
|
| 1 Week |
|
-0.74% |
| 1 Month |
|
+3.88% |
| 3 Month |
|
+12.13% |
| 6 Month |
|
-18.79% |
| 1 Year |
|
+3.88% |
| 2 Year |
|
+157.69% |
| 5 Year |
|
|
| 10 Year |
|
| 4 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 8.11 | 9.85 | 6.01 | 11.56 | |
| Return on Capital Employed (%) | 10.06 | 12.57 | 9.17 | 14.88 | |
| Return on Assets (%) | 4.23 | 6.53 | 4.30 | 7.46 |
| Particulars | 4 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Shh. Funds | 3 | 8 | 9 | 10 | |
| Non Curr. Liab. | 1 | 1 | 2 | 3 | |
| Curr. Liab. | 2 | 1 | 2 | 3 | |
| Minority Int. | |||||
| Equity & Liab. | 6 | 10 | 12 | 15 | |
| Non Curr. Assets | 2 | 4 | 4 | 6 | |
| Curr. Assets | 4 | 6 | 8 | 9 | |
| Misc. Exp. not W/O | 0 | 0 | 0 | 0 | |
| Total Assets | 6 | 10 | 12 | 15 |
| Particulars | 4 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Net Sales | 3 | 5 | 6 | 10 | |
| Other Income | 0 | 0 | |||
| Total Income | 3 | 5 | 6 | 10 | |
| Total Expenditure | -2 | -4 | -5 | -8 | |
| PBIDT | 1 | 1 | 1 | 2 | |
| Interest | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | -1 | |
| Taxation | 0 | 0 | 0 | 0 | |
| Exceptional Items | |||||
| PAT | 0 | 1 | 0 | 1 | |
| Adjusted EPS | 1 | 1 | 1 | 2 |
| Particulars | 4 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 0 | 0 | 1 | |
| Cash Fr. Inv. | -1 | -2 | -1 | -2 | |
| Cash Fr. Finan. | 2 | 4 | 1 | 2 | |
| Net Change | 1 | 1 | 0 | 1 | |
| Cash & Cash Eqvt | 1 | 2 | 2 | 3 |
|
Fri, 30 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM We wish to inform you that the members of the company at their 05th Annual General Meeting held on Friday 30th September 2022 at 03:00 p.m and concluded at 06:10 p.m at the 1st Floor 19C Club Road Punjabi Bagh West New Delhi - 110026 have transacted and voted on all the items of business as mentioned in notice of AGM. |
|
Fri, 30 Sep 2022
Proceedings At 05Th Annual General Meeting Of The Company Held On 30Th September 2022. We hereby submit summary of proceedings of the 05th Annual General Meeting of Dr. Lalchandani Labs Limited held on Friday 30th September 2022 at 03:00 p.m at 1st Floor 19C Club Road Punjabi Bagh West New Delhi - 110026 |
|
Thu, 08 Sep 2022
Fixes Book Closure For AGM Pursuant to Section 91 of the Companies Act 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Register of Members and Share Transfer books will remain closed from Wednesday September 21 2022 to Friday September 30 2022 (both days inclusive) for the purpose of the forthcoming 05th Annual General Meeting. |
| Fri, 30 Sep 2022 |
High Delivery Percentage
|
Opening at High
|
Opening at Low
|
Increasing Relative Strength - Sectoral Index
|
High Increase 3 Months
|
Equities
M.F.
Sectors